
Big pharma companies including Pfizer are planning to raise prices on more than 500 drugs this month, according to a recent Reuters report.
Using data from healthcare research firm 3 Axis Advisors, the report noted that prices will rise for 140 brands of drugs. When factoring in different doses and formulations, this number jumps to more than 500. Besides Pfizer, Sanofi, and Takeda Pharmaceuticals will also increase prices, it added.